BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 29678902)

  • 21. Estimating Individualized Absolute Risk for Esophageal Squamous Cell Carcinoma: A Population-Based Study in High-Risk Areas of China.
    Shen Y; Xie S; Zhao L; Song G; Shao Y; Hao C; Niu C; Ruan X; Zang Z; Nakyeyune R; Liu F; Wei W
    Front Oncol; 2020; 10():598603. PubMed ID: 33489898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast Cancer Knowledge Assessment of Health Workers in Ibadan, Southwest Nigeria.
    Pruitt LCC; Odedina S; Anetor I; Mumuni T; Oduntan H; Ademola A; Morhason-Bello IO; Ogundiran TO; Obajimi M; Ojengbede OA; Olopade OI
    JCO Glob Oncol; 2020 Mar; 6():387-394. PubMed ID: 32125900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Women in Uganda and Cameroon.
    Adedokun B; Zheng Y; Ndom P; Gakwaya A; Makumbi T; Zhou AY; Yoshimatsu TF; Rodriguez A; Madduri RK; Foster IT; Sallam A; Olopade OI; Huo D
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):359-367. PubMed ID: 31871109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A way forward for cancer prevention therapy: personalized risk assessment.
    Zhang Z; Bien J; Mori M; Jindal S; Bergan R
    Oncotarget; 2019 Dec; 10(64):6898-6912. PubMed ID: 31839883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of non-clinical risk models to aid prevention of breast cancer.
    Al-Ajmi K; Lophatananon A; Yuille M; Ollier W; Muir KR
    Cancer Causes Control; 2018 Oct; 29(10):967-986. PubMed ID: 30178398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance.
    Meads C; Ahmed I; Riley RD
    Breast Cancer Res Treat; 2012 Apr; 132(2):365-77. PubMed ID: 22037780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a Breast Cancer Risk Prediction Model for Women in Nigeria.
    Wang S; Ogundiran T; Ademola A; Olayiwola OA; Adeoye A; Sofoluwe A; Morhason-Bello I; Odedina S; Agwai I; Adebamowo C; Obajimi M; Ojengbede O; Olopade OI; Huo D
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):636-643. PubMed ID: 29678902
    [No Abstract]   [Full Text] [Related]  

  • 28. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the Nigerian Breast Cancer Study Model for Predicting Individual Breast Cancer Risk in Cameroon and Uganda.
    Ashi K; Ndom P; Gakwaya A; Makumbi T; Olopade OI; Huo D
    Cancer Epidemiol Biomarkers Prev; 2023 Jan; 32(1):98-104. PubMed ID: 36215182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model.
    Clendenen TV; Ge W; Koenig KL; Afanasyeva Y; Agnoli C; Brinton LA; Darvishian F; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Zeleniuch-Jacquotte A; Liu M
    Breast Cancer Res; 2019 Mar; 21(1):42. PubMed ID: 30890167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and external validation of a breast cancer absolute risk prediction model in Chinese population.
    Han Y; Lv J; Yu C; Guo Y; Bian Z; Hu Y; Yang L; Chen Y; Du H; Zhao F; Wen W; Shu XO; Xiang Y; Gao YT; Zheng W; Guo H; Liang P; Chen J; Chen Z; Huo D; Li L;
    Breast Cancer Res; 2021 May; 23(1):62. PubMed ID: 34051827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective approach to breast cancer risk prediction in African American women: the black women's health study model.
    Boggs DA; Rosenberg L; Adams-Campbell LL; Palmer JR
    J Clin Oncol; 2015 Mar; 33(9):1038-44. PubMed ID: 25624428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.
    Siu AL;
    Ann Intern Med; 2016 Feb; 164(4):279-96. PubMed ID: 26757170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.
    Oeffinger KC; Fontham ET; Etzioni R; Herzig A; Michaelson JS; Shih YC; Walter LC; Church TR; Flowers CR; LaMonte SJ; Wolf AM; DeSantis C; Lortet-Tieulent J; Andrews K; Manassaram-Baptiste D; Saslow D; Smith RA; Brawley OW; Wender R;
    JAMA; 2015 Oct; 314(15):1599-614. PubMed ID: 26501536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer risk after full-term pregnancies among African women from Nigeria, Cameroon, and Uganda.
    Sighoko D; Ogundiran T; Ademola A; Adebamowo C; Chen L; Odedina S; Anetor I; Ndom P; Gakwaya A; Ojengbede O; Huo D; Olopade OI
    Cancer; 2015 Jul; 121(13):2237-43. PubMed ID: 25781581
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.